Last $1.20 USD
Change Today -0.10 / -7.69%
Volume 3.9K
IFIT On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

isatori inc (IFIT) Snapshot

Open
$1.26
Previous Close
$1.30
Day High
$1.26
Day Low
$1.20
52 Week High
09/30/13 - $3.27
52 Week Low
08/1/14 - $1.20
Market Cap
15.5M
Average Volume 10 Days
4.1K
EPS TTM
$-0.03
Shares Outstanding
12.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ISATORI INC (IFIT)

Related News

No related news articles were found.

isatori inc (IFIT) Related Businessweek News

No Related Businessweek News Found

isatori inc (IFIT) Details

iSatori, Inc., a consumer products company, is engaged in the research, design, development, manufacture, marketing, sale, and distribution of various nutritional and dietary supplement products worldwide. It offers sports nutritionals; energy and sports drinks and shots; meal replacement proteins, protein-based products related to weight loss, and nutritional bars; and weight loss products. The company sells its products through online marketing, Fortune 500 retailers, and retail stores. iSatori, Inc. was founded in 2001 and is headquartered in Golden, Colorado.

22 Employees
Last Reported Date: 05/9/14
Founded in 2001

isatori inc (IFIT) Top Compensated Officers

Founder, Owner, Chairman, Chief Executive Off...
Total Annual Compensation: $225.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $126.0K
Compensation as of Fiscal Year 2013.

isatori inc (IFIT) Key Developments

iSatori, Inc. Releases the Results of a Brand-New Clinical Study on its Energy Pill, Energize

iSatori, Inc. released the results of a brand-new clinical study on its popular energy pill, Energize, titled 'Pharmacokinetics of caffeine administered in a time-release [Energize] versus regular tablet form'. The study, which was a double-blind, placebo-controlled, randomized clinical trial (the gold standard of studies), was performed by the Institute of Exercise Physiology and Wellness at the University of Central Florida (UCF) in Orlando and presented at this year's annual ISSN Conference in Clearwater, Florida on June 21, 2014. The clinical trial confirms the company's claims for extended energy when Energize is consumed from a single dose. Energize was compared in a double-blind, placebo-controlled, cross-over study to an equivalent dose of caffeine (194 mg) and a placebo. Blood was taken when the products were initially ingested and every subsequent hour for an eight-hour period. The researchers confirmed that while the common caffeine quickly reached its peak after three hours, with Energize, the caffeine didn't reach its peak until six full hours after ingestion and remained present for up to the eight hours. The UCF researchers concluded that absorption following Energize ingestion was both slower and more sustained, which could prolong the effects of caffeine and limit the common caffeine 'crash'.

iSatori, Inc. Announces the Results of the Clinical Study on Bio-Active Peptides (Bio-Gro(TM))

iSatori, Inc. announced the results of the clinical study on bio-active peptides (Bio-Gro(TM)) it funded, which was recently performed at the University of Central Florida Institute of Exercise Physiology and Wellness and presented at the Annual ISSN Scientific Conference in Clearwater, Florida.

iSatori Launches Amino-Amp(TM) and Isa-Test(R) DA3, Two New Innovative Products to Enhance Recovery, Training Performance, and Muscle Building

iSatori, Inc. announced the launch of two new innovative products, Amino-Amp(TM) and Isa-Test(R) DA3(TM), designed to enhance recovery, improve training performance, and help weight lifters with building muscle. Amino-Amp is a powered drink mix that contains a scientifically validated ratio of the three branched chain amino acids with the addition of MethioMax(TM) methionine that, when combined, increase the recovery, athletic performance, and muscle-building potential for weight-training individuals. Amino-Amp(TM) is the only product on the market that utilizes MethioMax(TM) to help amplify the effect of BCAA's. Isa-Test(R) DA3 is a powered drink mix that utilizes a proprietary formulation of botanicals, adaptagen herbs, and a uniquely new ingredient called DA3(TM) D-Aspartic Acid. The scientifically engineered formula in Isa-Test(R) DA3 is powered by three grams of DA3(TM), along with a supra-clinical dose of ashwagandha, to help stimulate the body's natural elevation of the muscle-building hormone, testosterone.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IFIT:US $1.20 USD -0.10

IFIT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.03 USD -0.09
USANA Health Sciences Inc $65.77 USD +1.92
Vitamin Shoppe Inc $42.15 USD -0.50
View Industry Companies
 

Industry Analysis

IFIT

Industry Average

Valuation IFIT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISATORI INC, please visit www.isatori.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.